Amniotic Fluid: Composition, Functions, and Clinical Disorders
Amniotic fluid (AF) is a dynamic fetal compartment essential for development. Volume peaks at approximately 800–1000 mL around 34–36 weeks, then declines to roughly 600 mL at term.
Composition (Evolving with Gestation)
- Early (<20 weeks): Transudate of maternal and fetal plasma—98% water, electrolytes, proteins, carbohydrates, lipids.
- Mid-to-late gestation: Fetal urine becomes the primary source (increasing urea, creatinine, uric acid); supplemented by lung fluid, vernix, lanugo, desquamated cells, antimicrobial peptides (defensins), growth factors (EGF, TGF-β), and stem cells.
Physiologic Functions
| Function | Mechanism |
|---|---|
| Mechanical protection | Cushions trauma; distributes force; prevents uterine wall adhesion |
| Thermoregulation | Maintains stable temperature (±0.5°C) |
| Musculoskeletal development | Provides space for movement → joint formation, muscle tone, chest wall compliance |
| Pulmonary development | Fetal breathing movements → lung expansion, surfactant production, alveolarization |
| Gastrointestinal maturation | Swallowing (200–750 mL/day) → gut priming, fluid balance |
| Chemical signaling | Growth factors, cytokines, hormones regulate fetal/organ maturation |
| Infection barrier | Antimicrobial peptides, IgA, complement; physical seal after membrane rupture |
Clinical Disorders
Oligohydramnios (AFI <5 cm or Maximum Vertical Pocket <2 cm)
- Causes: Preterm premature rupture of membranes (PPROM), placental insufficiency, renal agenesis/dysplasia, obstructive uropathy, post-dates pregnancy, medications (ACE inhibitors, ARBs, NSAIDs).
- Risks: Pulmonary hypoplasia, limb contractures (Potter sequence), cord compression, fetal growth restriction, cesarean delivery for non-reassuring fetal status.
- Management: Serial AFI monitoring, maternal hydration, amnioinfusion during labor, delivery timing based on gestational age.
Polyhydramnios (AFI >24 cm or Maximum Vertical Pocket >8 cm)
- Causes: Fetal anomalies (esophageal/duodenal atresia, anencephaly, CNS anomalies), maternal diabetes, twin-twin transfusion syndrome (monochorionic twins), infections (parvovirus, syphilis), idiopathic (~60%).
- Risks: Preterm labor, malpresentation, cord prolapse, placental abruption, postpartum hemorrhage.
- Management: Targeted anatomy scan, glucose tolerance testing, karyotype/chromosomal microarray, amnioreduction if symptomatic, treat underlying cause.
Diagnostic Amniocentesis
- Genetic: Karyotype, chromosomal microarray, exome sequencing (typically 15–20 weeks).
- Infection: PCR for CMV, toxoplasmosis, parvovirus, Zika.
- Fetal lung maturity: L/S ratio, phosphatidylglycerol, lamellar body count (rarely needed currently).
- Therapeutic: Amnioreduction, intrauterine transfusion, fetal surgery access.
Amniotic fluid volume and composition serve as windows into fetal well-being; serial ultrasound assessment remains the standard of care.
Infertility - Related Articles
- Chemical Pregnancy (Early Miscarriage): What It Is, Signs, and What to Expect
- HCG Injections: Side Effects, Risks & What You Need to Know
- Ultrasound Imaging: Benefits, Drawbacks & What to Expect
- Infertility Insurance Coverage: Understanding Your Options & Next Steps
- Can Transgender Women Give Birth? Understanding Current Biological Limits
- Ovulation in Adolescent Girls: Timing After Menarche
- Can You Get Pregnant During Your Period? Understanding the Possibility
